Siemens Healthineers AG (SHL):企業の財務・戦略的SWOT分析

◆英語タイトル:Siemens Healthineers AG (SHL) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME1717FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年2月
◆ページ数:72
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Siemens Healthineers AG (SHL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Siemens Healthineers AG (Siemens Healthineers), a subsidiary of Siemens AG, is a medical technology company that designs, develops, produces and distributes diagnostic imaging systems, clinical and workflow systems and solutions, and systems for minimally invasive procedures. The company’s major products include molecular imaging systems, X-ray products, ultrasound systems, computed tomography systems, magnetic resonance imaging systems, testing systems, point of care (POC) testing systems, mobile C-arms, hybrid ORs, and angiography systems. It also offers enterprise and digital services. Siemens Healthineers serves healthcare providers including laboratories, clinics, hospitals and hospital systems, physicians, public health agencies, universities, state-run and private health insurers, pharmaceutical companies, and clinical research institutes. The company operates in Europe, the Americas, the Middle East, Africa and Asia-Pacific. Siemens Healthineers is headquartered in Erlangen, Germany.

Siemens Healthineers AG Key Recent Developments

Feb 18,2021: Siemens Healthineers forms long-term partnership with Kantonsspital Baden
Feb 17,2021: Siemens Healthineers and Kantonsspital Baden form long-term partnership for improved patient care
Feb 12,2021: Annual Shareholders’ Meeting 2021: COVID-19 pandemic underlines social relevance of Siemens Healthineers
Feb 12,2021: Siemens Healthineers Annual Shareholders meeting approves all agenda items by a large majority
Feb 03,2021: Sysmex and Siemens Healthineers extend long-standing global alliance in hemostasis testing

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Siemens Healthineers AG – Key Facts
Siemens Healthineers AG – Key Employees
Siemens Healthineers AG – Key Employee Biographies
Siemens Healthineers AG – Major Products and Services
Siemens Healthineers AG – History
Siemens Healthineers AG – Company Statement
Siemens Healthineers AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Joint Venture
Section 2 – Company Analysis
Company Overview
Siemens Healthineers AG – Business Description
Business Segment: Advanced Therapies
Overview
Performance
Business Segment: Diagnostics
Overview
Performance
Business Segment: Imaging
Overview
Performance
Geographical Segment: Asia and Australia
Performance
Geographical Segment: Europe, C. I. S., Africa, Middle East (EMEA)
Performance
Geographical Segment: The Americas
Performance
R&D Overview
Siemens Healthineers AG – Corporate Strategy
Siemens Healthineers AG – SWOT Analysis
SWOT Analysis – Overview
Siemens Healthineers AG – Strengths
Siemens Healthineers AG – Weaknesses
Siemens Healthineers AG – Opportunities
Siemens Healthineers AG – Threats
Siemens Healthineers AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Siemens Healthineers AG, Medical Equipment, Deals By Year, 2015 to YTD 2021
Siemens Healthineers AG, Medical Equipment, Deals By Type, 2015 to YTD 2021
Siemens Healthineers AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 18, 2021: Siemens Healthineers forms long-term partnership with Kantonsspital Baden
Feb 17, 2021: Siemens Healthineers and Kantonsspital Baden form long-term partnership for improved patient care
Feb 12, 2021: Annual Shareholders’ Meeting 2021: COVID-19 pandemic underlines social relevance of Siemens Healthineers
Feb 12, 2021: Siemens Healthineers Annual Shareholders meeting approves all agenda items by a large majority
Feb 03, 2021: Sysmex and Siemens Healthineers extend long-standing global alliance in hemostasis testing
Feb 01, 2021: Darleen Caron appointed to Managing Board of Siemens Healthineers and Labor Director at Siemens Healthcare
Feb 01, 2021: Siemens Healthineers raises outlook for fiscal year 2021 after outstanding first quarter
Jan 28, 2021: Siemens, UK hospital operator sign partnership for medical equipment supply
Jan 28, 2021: Partnership between Manchester University NHS Foundation Trust and Siemens Healthineers set to transform care delivery
Jan 05, 2021: Siemens Healthineers proposes Peer Schatz to Annual Shareholders’ Meeting as new Supervisory Board member
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Siemens Healthineers AG, Key Facts
Siemens Healthineers AG, Key Employees
Siemens Healthineers AG, Key Employee Biographies
Siemens Healthineers AG, Major Products and Services
Siemens Healthineers AG, History
Siemens Healthineers AG, Other Locations
Siemens Healthineers AG, Subsidiaries
Siemens Healthineers AG, Affiliate
Siemens Healthineers AG, Joint Venture
Siemens Healthineers AG, Key Competitors
Siemens Healthineers AG, Ratios based on current share price
Siemens Healthineers AG, Annual Ratios
Siemens Healthineers AG, Annual Ratios (Cont...1)
Siemens Healthineers AG, Annual Ratios (Cont...2)
Siemens Healthineers AG, Interim Ratios
Siemens Healthineers AG, Medical Equipment, Deals By Year, 2015 to YTD 2021
Siemens Healthineers AG, Medical Equipment, Deals By Type, 2015 to YTD 2021
Siemens Healthineers AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Siemens Healthineers AG (SHL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Woori Bank:企業の戦略・SWOT・財務情報
    Woori Bank - Strategy, SWOT and Corporate Finance Report Summary Woori Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Nativis Inc-医療機器分野:企業M&A・提携分析
    Summary Nativis Inc (Nativis) is a clinical stage bio-electronics company. Its portfolio of pipeline candidates which are under development for various therapeutic areas include recurrent glioblastoma, brain metastisis, pain, rheumatoid arthritis, lung cancer and melanoma. The company’s lead product …
  • Actuate Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Actuate Therapeutics Inc (Actuate Therapeutics) is a biopharmaceutical company that offers development of novel compounds for the treatment of cancer and inflammatory diseases. The company’s lead compound 9-ING-41 is under evaluation for anti-tumor activity in various vivo models. It also de …
  • Tokio Marine Asia Pte. Ltd.
    Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • The Dixie Group Inc:企業の戦略・SWOT・財務情報
    The Dixie Group Inc - Strategy, SWOT and Corporate Finance Report Summary The Dixie Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • MGC Diagnostics Corp (MGCD):企業の財務・戦略的SWOT分析
    Summary MGC Diagnostics Corp (MGC Diagnostics) is a medical device company that provides cardio respiratory health solutions. The company provides PFT, metabolic CPET and CPX and indirect calorimetry products. Its PFT products include plethysmograph, pulmonary function systems, spirometry and forced …
  • Amtek Auto Limited:企業のM&A・事業提携・投資動向
    Amtek Auto Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amtek Auto Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Matsuda Sangyo Co Ltd (7456):企業の財務・戦略的SWOT分析
    Matsuda Sangyo Co Ltd (7456) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • BUCA, Inc.:企業の戦略・SWOT・財務情報
    BUCA, Inc. - Strategy, SWOT and Corporate Finance Report Summary BUCA, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Tokyo Broadcasting System Holdings Inc (9401):企業の財務・戦略的SWOT分析
    Tokyo Broadcasting System Holdings Inc (9401) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Shree Renuka Sugars Ltd (RENUKA):企業の財務・戦略的SWOT分析
    Shree Renuka Sugars Ltd (RENUKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • PTC KAMAZ:企業のM&A・事業提携・投資動向
    PTC KAMAZ - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PTC KAMAZ Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Plymouth Tube Company:企業の戦略的SWOT分析
    Plymouth Tube Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • WESCO International Inc (WCC)
    WESCO International Inc (WCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • eircom Holdings (Ireland) Ltd:企業の戦略・SWOT・財務情報
    eircom Holdings (Ireland) Ltd - Strategy, SWOT and Corporate Finance Report Summary eircom Holdings (Ireland) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Sermsuk Public Company Limited:企業の戦略・SWOT・財務分析
    Sermsuk Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sermsuk Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Diffusion Pharmaceuticals Inc (DFFN):企業の財務・戦略的SWOT分析
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a clinical stage biotechnology company that develops standard of care therapies. The company improves cancer treatments such as radiation therapy and chemotherapy in treatment-resistant solid tumors, includi …
  • Marina Biotech Inc (MRNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Marina Biotech Inc (Marina) is a nucleic acid-based drug discovery and development company that focuses on rare diseases. It focuses on treating the intersection of arthritis, hypertension, pain, and cancer using combination therapies of already approved drugs. The company is developing and …
  • Microsemi Corporation (MSCC):企業の財務・戦略的SWOT分析
    Microsemi Corporation (MSCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • ValiRx Plc (VAL):企業の財務・戦略的SWOT分析
    Summary ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The company’s products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE – BCL-2, and NAV3 cancer screening test. ValiRx uses GeneICE technology, which enables silen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆